Eli Lilly has seen revenue soar thanks to its blockbuster weight loss drug portfolio. Lilly and Novo Nordisk dominate this market, which has seen high demand. Though Lilly stock has climbed more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results